The Next Alzheimer's Disease Trial Needs Rapamycin This thought-provoking study advocates for human rapamycin trials in Alzheimer's disease. Why this drug? Rapa is already known for its anti-aging properties, as demonstrated in multiple experiments. Alzheimer's is an age-related illness. The theory is that targeting the aging processes may help slow or even prevent AD and…